149 related articles for article (PubMed ID: 15274321)
1. A novel quantitative chick embryo assay as an angiogenesis model using digital image analysis.
Peifer C; Dannhardt G
Anticancer Res; 2004; 24(3a):1545-51. PubMed ID: 15274321
[TBL] [Abstract][Full Text] [Related]
2. A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances.
Hazel SJ
J Lab Clin Med; 2003 Mar; 141(3):217-28. PubMed ID: 12624603
[TBL] [Abstract][Full Text] [Related]
3. Generational analysis reveals that TGF-beta1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels.
Parsons-Wingerter P; Elliott KE; Farr AG; Radhakrishnan K; Clark JI; Sage EH
Microvasc Res; 2000 Mar; 59(2):221-32. PubMed ID: 10684728
[TBL] [Abstract][Full Text] [Related]
4. A quantitative angiogenesis model for efficacy testing of chemopreventive agents.
Sharma S; Ghoddoussi M; Gao P; Kelloff GJ; Steele VE; Kopelovich L
Anticancer Res; 2001; 21(6A):3829-37. PubMed ID: 11911254
[TBL] [Abstract][Full Text] [Related]
5. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis.
Ribatti D; Vacca A; Roncali L; Dammacco F
Int J Dev Biol; 1996 Dec; 40(6):1189-97. PubMed ID: 9032025
[TBL] [Abstract][Full Text] [Related]
6. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.
Ng SS; Gütschow M; Weiss M; Hauschildt S; Teubert U; Hecker TK; Luzzio FA; Kruger EA; Eger K; Figg WD
Cancer Res; 2003 Jun; 63(12):3189-94. PubMed ID: 12810647
[TBL] [Abstract][Full Text] [Related]
8. A comparison of two controlled-release delivery systems for the delivery of amiloride to control angiogenesis.
Knoll A; Schmidt S; Chapman M; Wiley D; Bulgrin J; Blank J; Kirchner L
Microvasc Res; 1999 Jul; 58(1):1-9. PubMed ID: 10388598
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.
Sihn G; Walter T; Klein JC; Queguiner I; Iwao H; Nicolau C; Lehn JM; Corvol P; Gasc JM
FEBS Lett; 2007 Mar; 581(5):962-6. PubMed ID: 17316624
[TBL] [Abstract][Full Text] [Related]
10. 0.2 T magnetic field inhibits angiogenesis in chick embryo chorioallantoic membrane.
Ruggiero M; Bottaro DP; Liguri G; Gulisano M; Peruzzi B; Pacini S
Bioelectromagnetics; 2004 Jul; 25(5):390-6. PubMed ID: 15197764
[TBL] [Abstract][Full Text] [Related]
11. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment.
Seng WL; Eng K; Lee J; McGrath P
Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic activity of TZT-1027 (soblidotin) on chick chorioallantoic membrane and human umbilical vein endothelial cells.
Watanabe J; Endo Y; Shimada N; Natsume T; Sasaki T; Kobayashi M
In Vivo; 2007; 21(2):297-304. PubMed ID: 17436580
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis by THAM-derived cotelomers endowed with thalidomide moieties.
Périno S; Contino-Pépin C; Satchi-Fainaro R; Butterfield C; Pucci B
Bioorg Med Chem Lett; 2004 Jan; 14(2):421-5. PubMed ID: 14698173
[TBL] [Abstract][Full Text] [Related]
14. Osteocalcin is angiogenic in vivo.
Cantatore FP; Crivellato E; Nico B; Ribatti D
Cell Biol Int; 2005 Jul; 29(7):583-5. PubMed ID: 15979904
[TBL] [Abstract][Full Text] [Related]
15. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
[TBL] [Abstract][Full Text] [Related]
16. Use of the 10-day-old chick embryo model for studying angiogenesis.
Brooks PC; Montgomery AM; Cheresh DA
Methods Mol Biol; 1999; 129():257-69. PubMed ID: 10494570
[No Abstract] [Full Text] [Related]
17. Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay.
Baker JH; Huxham LA; Kyle AH; Lam KK; Minchinton AI
Microvasc Res; 2006 Mar; 71(2):69-75. PubMed ID: 16545400
[TBL] [Abstract][Full Text] [Related]
18. A novel radiological approach for the experimental study of angiogenesis: angiography of the chick embryo and its chorioallantoic membrane.
Siamblis D; Karnabatidis D; Hatjikondi O; Kalogeropoulou C; Kardamakis D; Dimopoulos J
Eur J Radiol; 1996 Feb; 21(3):220-4. PubMed ID: 8777914
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of angiogenesis in the chick chorioallantoic membrane model using fractal analysis.
Kirchner LM; Schmidt SP; Gruber BS
Microvasc Res; 1996 Jan; 51(1):2-14. PubMed ID: 8812748
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
